General Information of Drug (ID: DM8ZWSF)

Drug Name
KamRAB
Indication
Disease Entry ICD 11 Status REF
leukaemia 2A60-2B33 Phase 2/3 [1]
Cross-matching ID
TTD ID
D02URX

References

1 ClinicalTrials.gov (NCT02040090) Phase II/III Study of the Safety and Effectiveness of HRIG With Co-administration of Active Rabies Vaccine in Healthy Subjects. U.S. National Institutes of Health.